Full Press Release Details
CRISPR Therapeutics to Participate in the Chardan’s 5th Annual Genetic Medicines Conference.
CRSP
CRISPR Therapeutics to Participate in the Chardan’s 5th Annual Genetic Medicines Conference
Key Takeaway: CRISPR Therapeutics to Participate in the Chardan’s 5th Annual Genetic Medicines Conference
Price reaction · baseline $117.26 (2021-09-27 close) · hit after-hours · 1 other CRSP headline(s) in the window, move may be shared
day 0 close · peak
-4.4%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+60%
120-day peak, hindsight
Typical move
2.4%
average across 2 past catalysts
Cash runway
~84 mo
Minimal dilution risk
Lead asset
CTX340
Phase 1 · Hypertension